Results 141 to 150 of about 30,781 (201)

Genetic factors of clopidogrel resistance

open access: yes, 2012
Ievads. Klopidogrels ir antiagregants, kas indicēts akūta koronāra sindroma, perkutānas koronāras intervences (PCI), īpaši ar zālēm pārklāta stenta (DES) implantācijas gadījumā.
Pučeta, Laura
core  

Overcoming Clopidogrel Resistance in Carotid Artery Stenting: Experience with Ticagrelor and Ticlopidine. [PDF]

open access: yesClin Pract
Vigláš P   +6 more
europepmc   +1 more source

A 4-year cross-sectional study on the basic demography and Clopidogrel resistance profile

open access: yes
Background and aim: Stroke is a leading cause of death and disability worldwide. Clopidogrel is widely used to prevent recurrent strokes in acute ischemic stroke patients, but clopidogrel resistance remains a significant concern due to various factors.
Humardani, Farizky Martriano   +2 more
core  

Clopidogrel Resistance

open access: yesKorean Journal of Medicine, 2013
openaire   +1 more source

Aspirin and clopidogrel resistance: Possible mechanisms and clinical relevance. Part I: Concept of resistance

open access: yes, 2012
Aspirin and clopidogrel are well established as antiplatelet medication in the treatment of atherothrombotic vascular disease. However, despite treatment, a substantial number of patients experience recurrent ischemic episodes, referred to as aspirin or ...
Vécsei László   +3 more
core  

Prevalence of clopidogrel resistance in patients with atrial fibrillation undergoing percutaneous coronary intervention. [PDF]

open access: yesPostepy Kardiol Interwencyjnej
Błaziak M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy